12
Participants
Start Date
October 31, 2015
Primary Completion Date
November 7, 2018
Study Completion Date
November 7, 2018
MPDL3280A
Patients will receive 1,200 mg I.V. Q 3 weeks of MPDL3280A until progression.
Hypofractionated Radiotherapy
Hypofractionated Image-Guided Radiotherapy (HIGRT)
The University of Michigan Comprehensive Cancer Center, Ann Arbor
University of Washington, Seattle, Seattle
University of Washington
OTHER
University of Michigan Rogel Cancer Center
OTHER